1. 198 OUTCOME OF AZACITIDINE TREATMENT AND INCIDENCE OF FEBRILE EVENTS IN "REAL WORLD" PATIENTS WITH MDS OR LOW-BLAST COUNT AML. Issue 1 (April 2015) Authors: Voso, M.T.; Niscola, P.; Piciocchi, A.; Fianchi, L.; Maurillo, L.; Musto, P.; Pagano, L.; Mansueto, G.; Criscuolo, M.; Aloe-Spiriti, M.A.; Buccisano, F.; Venditti, A.; Tendas, A.; Piccioni, A.L.; Zini, G.; Latagliata, R.; Filardi, N.; Fragasso, R.; Fenu, S.; Breccia, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Real-Life Study of Deferasirox in Patients with Higher Risk Myelodysplastic Syndromes. (April 2017) Authors: Musto, P.; Maurillo, L.; Simeon, V.; Poloni, A.; Finelli, C.; Balleari, E.; Ricco, A.; Rivellini, F.; Cortelezzi, A.; Tarantini, G.; Villani, O.; Breccia, M.; Niscola, P.; Sanna, A.; Clissa, C.; Voso, M.T.; Fenu, S.; Venditti, A.; Santini, V.; Angelucci, E. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction. Issue 3 (March 2015) Authors: Ramos, F.; Thépot, S.; Pleyer, L.; Maurillo, L.; Itzykson, R.; Bargay, J.; Stauder, R.; Venditti, A.; Seegers, V.; Martínez-Robles, V.; Burgstaller, S.; Récher, C.; Debén, G.; Gaidano, G.; Gardin, C.; Musto, P.; Greil, R.; Sánchez-Guijo, F.; Fenaux, P.; for the European ALMA Investigators, 1 Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of mRNA Expression of Genes Involved in Megakaryocyte Development in Higher-Risk Myelodysplastic Syndromes. (April 2017) Authors: Fabiani, E.; Falconi, G.; Criscuolo, M.; Fianchi, L.; Picardi, A.; Buccisano, F.; Maurillo, L.; Coco, F. Lo; Voso, M.T. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. (April 2023) Authors: Maurillo, L.; Spagnoli, A.; Candoni, A.; Papayannidis, C.; Borlenghi, E.; Lazzarotto, D.; Fianchi, L.; Sciumè, M.; Zannier, M.E.; Buccisano, F.; Del Principe, M.I.; Mancini, V.; Breccia, M.; Fanin, R.; Todisco, E.; Lunghi, M.; Palmieri, R.; Fracchiolla, N.; Musto, P.; Rossi, G. Journal: Leukemia research Issue: Volume 127(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression Profile of Bone Marrow Mesenchymal Stromal Cells Isolated from Patients with Therapy-Related Myeloid Neoplasms. (April 2017) Authors: Falconi, G.; Fabiani, E.; Criscuolo, M.; Fianchi, L.; Buccisano, F.; Maurillo, L.; Ottone, T.; D'Alò, F.; Laurenti, L.; Hohaus, S.; Lo-Coco, F.; Voso, M.T. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P434: MITOCONDRIAL MCL1 REGULATES LEUKEMIC CELLS METABOLISM VIA DIRECT INTERACTION WITH HEXOKINASE II. METABOLIC SIGNATURE AT ONSET PREDICTS OVERALL SURVIVAL IN AMLS' PATIENTS. (23rd June 2022) Authors: Noguera, N. I.; Catalano, G.; Zaza, A.; Banella, C.; Ottone, T.; Pelosi, E.; Travaglini, S.; Divona, M.; Del Principe, M. I.; Buccisano, F.; Maurillo, L.; Amatuna, E.; Testa, U.; Venditti, A.; Voso, M. T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PB1835: THE ISTH-DIC SCORE PREDICTS 30-DAYS OUTCOME IN NON-M3 ACUTE MYELOID LEUKEMIA PATIENTS. (23rd June 2022) Authors: Paterno, G.; Palmieri, R.; Forte, V.; Bonanni, F.; Guarnera, L.; Mallegni, F.; Pascala, M. R.; Elisa, B.; Moretti, F.; Savi, A.; Maurillo, L.; Buccisano, F.; Venditti, A.; Del Principe, M. I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: THE GENE EXPRESSION PROFILE OF GENES BELONGING TO TRANSFORMING GROWTH FACTOR-B PATHWAY IS DEREGULATED IN SF3B1 MUTATED LOW-RISK MDS PATIENTS. (May 2023) Authors: Fabiani, E.; Hajrullaj, H.; Cristiano, A.; Silvestrini, G.; Galossi, E.; Falconi, G.; Hutter, S.; Nadarajah, N.; Maurillo, L.; Latagliata, R.; Haferlach, T.; Voso, M.T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Topic: AS09-Quality of life-Disease experiences: EXPLORING UNMET NEEDS OF MDS PATIENTS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY. (May 2023) Authors: Crisà, E.; Nosari, A.; Cilloni, D.; Salek, S.; Ionova, T.; Della Porta, M.; Voso, M.T.; Maurillo, L.; Finelli, C.; Santini, V.; Balleari, E.; Pilo, F.; Palumbo, G.; Molteni, A.; Riva, M.; Oliva, E. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗